Mast-Cell Stabilizing Effects of Olopatadine

Phase 4CompletedNCT00389025

Alcon Research24 enrolled

Overview

To assess the effects of olopatadine of the release of mast cell histamine

Study Type

INTERVENTIONAL

Allocation

RANDOMIZED

Purpose

PREVENTION

Masking

DOUBLE

Enrollment

Sex: ALLMin age: 18 YearsHealthy volunteers:

Medical Language ↔ Plain English

Inclusion Criteria: * Asymptomatic and not using any topical or systemic medication Exclusion Criteria: * Age

Padova Site

Padua, Padova, Italy

Tear histamine

Tear cytology, subject evaluation of ocular itching, investigators evaluation of ocular redness

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.